Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.415
-0.115 (-3.26%)
At close: Jul 17, 2026, 4:00 PM EDT
3.430
+0.015 (0.44%)
After-hours: Jul 17, 2026, 4:10 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $18.46 million as of July 17, 2026. Its market cap has increased by 31.68% in one year.
Market Cap
18.46M
Enterprise Value
-949.89K
1-Year Change
31.68%
Ranking
Category
Stock Price
$3.42
ChartMarket Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $18.46M, an increase of 71.07%. That is a compound annual growth rate of 41.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 18.46M | -11.54% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 20.45M |
| Pluri | 20.07M |
| Cellectar Biosciences | 20.06M |
| Longeveron | 19.65M |
| Akari Therapeutics, | 19.27M |
| Allarity Therapeutics | 18.93M |
| Quince Therapeutics | 18.46M |
| Lipocine | 18.38M |